Biopharmas raising money in public or private financings, including: Bioatla, Envisagenics, Oak Bay, Onconova, Pharmather.

Biopharmas raising money in public or private financings, including: Acrigen, Anji, Diamedica, Hadean, Hillstream, Kytopen, NLS.

Biopharmas raising money in public or private financings, including: Aglaia, Astrazeneca, Cingulate, Corium, Diamedica, Ensysce, Exscientia, Leap, Santhera, Skye, Procella, Smartcella, Smartwise, Svedmed.

Biopharmas raising money in public or private financings, including: Alpha Cognition, Eurazeo, Kintara, Kurma, Onconova, Pharmather, Underdog, Viridian.

Biopharmas raising money in public or private financings, including: Garuda, Genedit, Synlogic.

Biopharmas raising money in public or private financings, including: Leap, Opus, Oxford, RD Fund, Serum.

Biopharmas raising money in public or private financings, including: Atyr, Fauna, Galectin, Galapagos, Mycrodose, Viridian.

LONDON – There were well-deserved celebrations in Paris on Sept. 20, as Jeito Capital toasted the oversubscribed close of its first fund at €534 million (US$625.5 million). This is claimed as the largest European venture fund dedicated to life sciences, exceeding the original target of €500 million, and with €340 million of the total raised under the constraints of the pandemic from January 2020 onward.